Literature DB >> 8657571

A nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-kappa(B) activity.

T Hoover1, J Mikovits, D Court, Y L Liu, H F Kung.   

Abstract

The negative regulatory element (NRE) of human immunodeficiency virus type-1 (HIV-1) long terminal repeat (LTR) is a defined region that has been reported to downregulate LTR-directed HIV gene expression. However, information on the precise role of this region in regulating HIV gone transcription is lacking. We have investigated the possibility that these NRE sequences regulate HIV transcription by a mechanism mediated through a nuclear matrix-specific DNA-protein interaction. We find a nuclear matrix attachment region (MAR) present within the NRE of the HIV-1 LTR that recognizes a sequence-specific DNA-binding protein present in the nuclear matrix of HIV infected cells. Moreover, we also show that the purified DNA-binding nuclear matrix protein (NMP) specifically represses the DNA-binding activity of NF-kappaB. It is likely that the MAR and MAR-enriched specific DNA-binding NMP are brought into juxtaposition by the non-chromatin scaffolding of the nucleus, thus influencing NF-kappaB (and other nuclear proteins) DNA-binding activity through protein-protein and protein-DNA interactions. Our date suggest that one possible role of the NRE could be to act as a matrix attachment site in the nuclear matrix, thus, allowing interaction with a sequence-specific trans-acting factor. The negative effect on NF-kappaB activity due to this MAR-NMP-specific interaction provides a mechanism by which the NRE downregulates HIV gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8657571      PMCID: PMC145884          DOI: 10.1093/nar/24.10.1895

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Binding of matrix attachment regions to lamin B1.

Authors:  M E Ludérus; A de Graaf; E Mattia; J L den Blaauwen; M A Grande; L de Jong; R van Driel
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Sequence-specific DNA-binding proteins are components of a nuclear matrix-attachment site.

Authors:  S I Dworetzky; K L Wright; E G Fey; S Penman; J B Lian; J L Stein; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

4.  Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency.

Authors:  T Folks; D M Powell; M M Lightfoote; S Benn; M A Martin; A S Fauci
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

5.  Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.

Authors:  P N Cockerill; W T Garrard
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

6.  Nuclear matrix proteins reflect cell type of origin in cultured human cells.

Authors:  E G Fey; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

7.  Identification and characterization of a nuclear scaffold protein that binds the matrix attachment region DNA.

Authors:  K Tsutsui; K Tsutsui; S Okada; S Watarai; S Seki; T Yasuda; T Shohmori
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

8.  Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold.

Authors:  J Mirkovitch; M E Mirault; U K Laemmli
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

9.  A cluster of strong topoisomerase II cleavage sites is located near an integrated human immunodeficiency virus.

Authors:  M T Howard; J D Griffith
Journal:  J Mol Biol       Date:  1993-08-20       Impact factor: 5.469

10.  Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components.

Authors:  J P Bidwell; A J Van Wijnen; E G Fey; S Dworetzky; S Penman; J L Stein; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more
  6 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions.

Authors:  Masahide Horiba; Lindsey B Martinez; James L Buescher; Shinji Sato; Jenae Limoges; Yunquan Jiang; Clinton Jones; Tsuneya Ikezu
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

3.  In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat.

Authors:  J Xiao; G C Buehring
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.

Authors:  Matthew Bayer; Boris Kantor; Adam Cockrell; Hong Ma; Brian Zeithaml; Xiangping Li; Thomas McCown; Tal Kafri
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

5.  Host Proteins Ku and HMGA1 As Participants of HIV-1 Transcription.

Authors:  O A Shadrina; E S Knyazhanskaya; S P Korolev; M B Gottikh
Journal:  Acta Naturae       Date:  2016 Jan-Mar       Impact factor: 1.845

Review 6.  Pectin Oligosaccharides Ameliorate Colon Cancer by Regulating Oxidative Stress- and Inflammation-Activated Signaling Pathways.

Authors:  Haidong Tan; Wei Chen; Qishun Liu; Guojun Yang; Kuikui Li
Journal:  Front Immunol       Date:  2018-06-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.